Literature DB >> 27599973

Comparison of three magnetic resonance enterography indices for grading activity in Crohn's disease.

Jordi Rimola1, Almudena Alvarez-Cofiño2, Tamara Pérez-Jeldres3, Carmen Ayuso1,4, Ignacio Alfaro5, Sonia Rodríguez1, Elena Ricart5,4, Ingrid Ordás5, Julián Panés6,7.   

Abstract

BACKGROUND: Magnetic resonance enterography (MRE) is an accurate examination for assessing activity in Crohn's disease (CD). Various MRE indices have been developed for that purpose, but have not been directly compared. The aim of the study was to compare the diagnostic accuracy of three MRE indices for detecting and grading disease activity in CD, using endoscopy as gold standard.
METHODS: MRE and ileocolonoscopies performed within 1 month in 43 patients with CD were analyzed. The magnetic resonance index of activity (MaRIA), Clermont, and London indices for each colonic segment and the terminal ileum were calculated. Simplified endoscopy score for CD (SES-CD) was considered the gold standard.
RESULTS: Two hundred and twenty-four intestinal segments were included in the analysis. According to the established cut-off points for detecting active disease using MaRIA, Clermont, and London indices, the sensitivity of each index was 0.88, 0.89, and 0.71, and the specificity was 0.97, 0.78, and 0.99, respectively. The sensitivity for detecting ulcerations was 0.90 and 0.83 for the MaRIA and Clermont indices, respectively, with a specificity of 0.91 and 0.89. The AUROC curve for the MaRIA, Clermont, and London indices for detecting active disease was 0.92, 0.84, and 0.85, and for detecting ulcerations was 0.90 for the MaRIA, and 0.86 for Clermont index.
CONCLUSIONS: The three MRE-based indices evaluated in the current study have high diagnostic accuracy for assessment of disease activity. The MaRIA index has the best operational characteristics for detecting not only disease activity but also for grading severity, which supports its use in clinical studies and clinical practice.

Entities:  

Keywords:  Crohn’s disease; Diagnostic accuracy; Diffusion-weighted imaging; Disease activity; Disease complications; Magnetic resonance enterography

Mesh:

Year:  2016        PMID: 27599973     DOI: 10.1007/s00535-016-1253-6

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  22 in total

1.  Comparison of Diagnostic Accuracy and Impact of Magnetic Resonance Imaging and Colonoscopy for the Management of Crohn's Disease.

Authors:  O García-Bosch; I Ordás; M Aceituno; S Rodríguez; A M Ramírez; M Gallego; E Ricart; J Rimola; J Panes
Journal:  J Crohns Colitis       Date:  2016-01-18       Impact factor: 9.071

2.  Evaluation of Crohn's disease activity: initial validation of a magnetic resonance enterography global score (MEGS) against faecal calprotectin.

Authors:  Jesica C Makanyanga; Doug Pendsé; Nikolaos Dikaios; Stuart Bloom; Sara McCartney; Emma Helbren; Elaine Atkins; Terry Cuthbertson; Shonit Punwani; Alastair Forbes; Steve Halligan; Stuart A Taylor
Journal:  Eur Radiol       Date:  2013-09-12       Impact factor: 5.315

3.  Magnetic resonance enterocolonography is useful for simultaneous evaluation of small and large intestinal lesions in Crohn's disease.

Authors:  Sea Bong Hyun; Yoshio Kitazume; Masakazu Nagahori; Akira Toriihara; Toshimitsu Fujii; Kiichiro Tsuchiya; Shinji Suzuki; Eriko Okada; Akihiro Araki; Makoto Naganuma; Mamoru Watanabe
Journal:  Inflamm Bowel Dis       Date:  2010-10-25       Impact factor: 5.325

4.  Non-perforating small bowel Crohn's disease assessed by MRI enterography: derivation and histopathological validation of an MR-based activity index.

Authors:  Michael J Steward; Shonit Punwani; Ian Proctor; Yvette Adjei-Gyamfi; Fiona Chatterjee; Stuart Bloom; Marco Novelli; Steve Halligan; Manuel Rodriguez-Justo; Stuart A Taylor
Journal:  Eur J Radiol       Date:  2011-09-15       Impact factor: 3.528

5.  Value of endoscopy and MRI for predicting intestinal surgery in patients with Crohn's disease in the era of biologics.

Authors:  A Jauregui-Amezaga; J Rimola; I Ordás; S Rodríguez; A Ramírez-Morros; M Gallego; M C Masamunt; J Llach; B González-Suárez; E Ricart; J Panés
Journal:  Gut       Date:  2014-12-16       Impact factor: 23.059

6.  Risk factors associated with progression to intestinal complications of Crohn's disease in a population-based cohort.

Authors:  Kelvin T Thia; William J Sandborn; William S Harmsen; Alan R Zinsmeister; Edward V Loftus
Journal:  Gastroenterology       Date:  2010-07-14       Impact factor: 22.682

7.  MRI scoring system including dynamic motility evaluation in assessing the activity of Crohn's disease of the terminal ileum.

Authors:  Rossano Girometti; Chiara Zuiani; Francesco Toso; Giovanni Brondani; Dario Sorrentino; Claudio Avellini; Massimo Bazzocchi
Journal:  Acad Radiol       Date:  2008-02       Impact factor: 3.173

8.  External validation is necessary in prediction research: a clinical example.

Authors:  S E Bleeker; H A Moll; E W Steyerberg; A R T Donders; G Derksen-Lubsen; D E Grobbee; K G M Moons
Journal:  J Clin Epidemiol       Date:  2003-09       Impact factor: 6.437

9.  Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn's disease.

Authors:  J Rimola; S Rodriguez; O García-Bosch; I Ordás; E Ayala; M Aceituno; M Pellisé; C Ayuso; E Ricart; L Donoso; J Panés
Journal:  Gut       Date:  2009-01-09       Impact factor: 23.059

10.  Diffusion-weighted magnetic resonance imaging in ileocolonic Crohn's disease: validation of quantitative index of activity.

Authors:  C Hordonneau; A Buisson; J Scanzi; F Goutorbe; B Pereira; C Borderon; D Da Ines; P F Montoriol; J M Garcier; L Boyer; G Bommelaer; V Petitcolin
Journal:  Am J Gastroenterol       Date:  2013-11-19       Impact factor: 10.864

View more
  22 in total

1.  What score should be used for evaluation of Crohn's disease severity using magnetic resonance imaging?

Authors:  Anthony Buisson; Constance Hordonneau; Marion Goutte; Gilles Bommelaer
Journal:  J Gastroenterol       Date:  2016-12-29       Impact factor: 7.527

2.  Bowel wall healing assessed using magnetic resonance imaging predicts sustained clinical remission and decreased risk of surgery in Crohn's disease.

Authors:  Anthony Buisson; Constance Hordonneau; Felix Goutorbe; Christophe Allimant; Marion Goutte; Maud Reymond; Bruno Pereira; Gilles Bommelaer
Journal:  J Gastroenterol       Date:  2018-08-30       Impact factor: 7.527

3.  The new simplified MARIA score applies beyond clinical trials: A suitable clinical practice tool for Crohn's disease that parallels a simple endoscopic index and fecal calprotectin.

Authors:  Joana Roseira; Ana Rita Ventosa; Helena Tavares de Sousa; Jorge Brito
Journal:  United European Gastroenterol J       Date:  2020-07-14       Impact factor: 4.623

Review 4.  Artificial Intelligence for Disease Assessment in Inflammatory Bowel Disease: How Will it Change Our Practice?

Authors:  Ryan W Stidham; Kento Takenaka
Journal:  Gastroenterology       Date:  2022-01-04       Impact factor: 22.682

5.  MR Enterography in Crohn's Disease: Comparison of Contrast Imaging with Diffusion-weighted Imaging and a special Form of Color Coding.

Authors:  Maja Jakob; Maik Backes; Christian Schaefer; Joerg Albert; Angela Geissler
Journal:  Rofo       Date:  2022-06-15

6.  Assessing the inflammatory severity of the terminal ileum in Crohn disease using radiomics based on MRI.

Authors:  Honglei Ding; Jiaying Li; Kefeng Zhou; Zhichao Sun; Kefang Jiang; Chen Gao; Liangji Lu; Huani Zhang; Haibo Chen; Xuning Gao
Journal:  BMC Med Imaging       Date:  2022-07-04       Impact factor: 2.795

7.  Diffusion and perfusion MRI quantification in ileal Crohn's disease.

Authors:  Stefanie J Hectors; Sonja Gordic; Sahar Semaan; Octavia Bane; Robert Hirten; Xiaoyu Jia; Jean-Frederic Colombel; Bachir Taouli
Journal:  Eur Radiol       Date:  2018-07-17       Impact factor: 5.315

8.  Assessment of Ileocolonic Inflammation in Crohn's Disease: Which Surrogate Marker Is Better-MaRIA, Clermont, or PET/MR Index? Initial Results of a Feasibility Trial.

Authors:  Yan Li; Jost Langhorst; Anna Katharina Koch; Aydin Demircioglu; Felix Nensa; Julian Kirchner; Karsten Beiderwellen; Onofrio Catalano; Michael Forsting; Ken Herrmann; Lale Umutlu
Journal:  J Nucl Med       Date:  2018-11-02       Impact factor: 10.057

9.  Magnetic resonance enterography features of small bowel Crohn's disease activity: an inter-rater reliability study of small bowel active inflammation in clinical practice setting.

Authors:  Richard Tsai; Aaron Mintz; Michael Lin; Joyce Mhlanga; Adeeti Chiplunker; Amber Salter; Matthew Ciorba; Parakkal Deepak; Kathryn Fowler
Journal:  Br J Radiol       Date:  2019-05-29       Impact factor: 3.039

10.  Faecal calprotectin and magnetic resonance imaging in detecting Crohn's disease endoscopic postoperative recurrence.

Authors:  Pierre Baillet; Guillaume Cadiot; Marion Goutte; Felix Goutorbe; Hedia Brixi; Christine Hoeffel; Christophe Allimant; Maud Reymond; Hélène Obritin-Guilhen; Benoit Magnin; Gilles Bommelaer; Bruno Pereira; Constance Hordonneau; Anthony Buisson
Journal:  World J Gastroenterol       Date:  2018-02-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.